Frequently Asked Questions
Still Have Questions?
Nicotine dependence occurs when the body becomes accustomed to regular nicotine exposure, leading to cravings or withdrawal symptoms when use is reduced or stopped. It is a recognised health condition and can affect people differently depending on usage patterns, duration, and individual factors. Clinical assessment can help determine appropriate support options.
Quitting smoking can be difficult due to both physical dependence on nicotine and behavioural habits developed over time. Triggers such as stress, routines, and social environments can also play a role. Many people benefit from structured support, education, and clinically guided approaches to help manage these challenges.
In Australia, smoking cessation support may include behavioural strategies, counselling, and first-line smoking cessation therapies such as nicotine replacement options (including patches, gum, nicotine pouches, and lozenges). In some cases, regulated prescription pathways may be considered following clinical assessment, in line with Australian health regulations.
It is generally recognised that stopping smoking can be beneficial at any stage. Many people choose to seek support later in life, often with guidance from healthcare professionals. The most appropriate approach varies between individuals and should be based on personal health circumstances and clinical advice.
Nicotine dependence is assessed through a structured clinical review, which may include questions about smoking history, frequency, previous quit attempts, and other health factors. myduke® uses this information to guide professional advice and develop a safe and personalised smoking cessation treatment plan.
Therapeutic vaping products are nicotine-containing vaping substances that are regulated in Australia for use in smoking cessation or nicotine dependence management. They are supplied within a medical or pharmacist-led framework and are intended for adult smokers seeking support to quit cigarettes, rather than for recreational or lifestyle use.
In Australia, nicotine vaping products are regulated and may be accessed by adults through approved clinical pathways. Access requires assessment by a registered healthcare practitioner and supply through authorised pharmacy channels, in accordance with Australian law and regulatory requirements.
Australian regulations restrict access to nicotine vaping products to ensure safety and appropriate use. Depending on nicotine strength, access may involve consultation with a pharmacist or a prescription from a medical practitioner. These regulations are designed to limit inappropriate access while supporting harm reduction for adult smokers.
Nicotine vaping products are classified as unapproved therapeutic goods because they have not been evaluated by the Therapeutic Goods Administration (TGA) for safety, quality, or efficacy. Their supply is permitted under specific regulatory pathways that allow controlled access for smoking cessation or nicotine dependence, under professional supervision.
Yes. Nicotine vaping products are unapproved therapeutic goods in Australia and have not been evaluated by the TGA for safety, quality, or efficacy. Use may carry health risks, particularly if not managed under clinical supervision. Adults seeking support should follow professional guidance and use regulated pathways to reduce potential harm.
To begin, adults complete a secure online medical questionnaire. This gathers relevant health and smoking history and forms the basis for a clinical assessment for nicotine dependence. The information is then reviewed by an independent Australian-registered doctor.
Yes. Registered Australian medical and nurse practitioners can prescribe therapeutic nicotine vaping products when clinically appropriate. Prescriptions are typically issued through streamlined Therapeutic Goods Administration access pathways after a clinical review to ensure suitability and alignment with public health guidance.
The timeframe depends on the review of your clinical assessment by a registered doctor, which is typically completed within 24 hours. Where clinically appropriate, the prescription is then issued in line with standard medical review procedures.
No. Only prescriptions issued through myduke®’s authorised prescribers can be used. This ensures treatment is managed through a consistent clinical pathway in line with regulatory and professional standards.
When your prescription expires, a clinical review is required to ensure continued treatment remains appropriate. You can request a renewal directly through your myduke® account, which is then sent to a doctor for re-evaluation.
Once an order has been processed by the dispensing partner and dispatched via registered express post, changes aren’t possible. This is because prescribed medicines must be managed in accordance with clinical and legal requirements.
Medicines cannot be returned for change of mind once dispensed, due to legal and safety requirements.
Patients located near the dispensing pharmacy in Melbourne may arrange to collect their order directly. All pickups must be coordinated with our patient services team and pharmacy
No. Prescribed medicines cannot be returned or refunded once dispensed, as legislation prohibits it. This is a safety and quality safeguard, not a commercial policy.
Inspect your order when it arrives. If you receive something that’s incorrect or appears damaged, contact our patient services team promptly
No referral is required. Adults can initiate the process directly by completing the secure online medical questionnaire. This assessment is reviewed by a registered Australian doctor, who determines the most appropriate clinical pathway for smoking cessation support.
Yes. The myduke® digital platform is designed to provide structured smoking cessation support to adults across Australia. The online assessment and clinical review process enable people in regional or remote locations to receive guidance from registered healthcare professionals.
Each assessment is reviewed individually by an independent Australian-registered doctor. Treatment recommendations are based on clinical factors, nicotine dependence history, and personal circumstances to support safe and evidence-informed decision-making.
myduke® does not manage private health insurance claims. Whether costs can be claimed depends on your individual policy and insurer rules. Contact your insurer directly for clarification.
In Australia there are strict regulations regarding the advertising of prescription medicines. For this reason, pricing and product details cannot be provided before a clinical consultation.
Our goal is to provide access to a range of TGA-compliant products at different price points to suit individual needs. Due to Australian advertising restrictions on prescription medicines, pricing information can only be provided after a clinical consultation.
Nicotine products are provided within regulated pathways for adults residing in Australia. Prescriptions and supply are subject to Australian health regulations, and eligibility may differ for non-residents.